Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication

Clinical and Experimental Immunology

Volumn 157, Issue 3, 2009, Pages 400-407

  Damas J K ^a,b,c   Landro L ^a   Fevang, B ^a,b   Heggelund, L ^a   Tjonnfjord G E ^b   Floisand Y ^b   Halvorsen, B ^a   Froland S S ^a,b   Aukrust, P ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Chemokines; HIV infection; Inflammation; Lymphocytes

Indexed keywords

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PHYTOHEMAGGLUTININ; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSACTIVATOR PROTEIN;

ADULT; ARTICLE; BONE MARROW MONONUCLEAR CELL; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE HOMING; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT FAILURE; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE MARROW CELLS; CASE-CONTROL STUDIES; CHEMOKINE CCL19; CHEMOKINE CCL21; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HOMEOSTASIS; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; MALE; RECEPTORS, CCR7; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TREATMENT FAILURE; VIRAL LOAD; VIRUS REPLICATION; YOUNG ADULT;

EID: 67651225596     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03976.x     Document Type: Article

References (24)

1. Moser B, Wolf M, Walz A et al. Chemokines: multiple levels of leukocyte migration control. Trends Immunol 2004 25 : 75 84.
2. Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007 25 : 787 820.
3. DeVico AL, Gallo RC. Control of HIV-1 infection by soluble factors of the immune response. Nat Rev Microbiol 2004 2 : 401 13.
4. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999 17 : 657 700.
5. Boasso A, Shearer GM. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008 126 : 235 42.
6. Förster R, Schubel A, Breitfeld D et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1991 99 : 23 33.
7. Müller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 2003 195 : 117 35.
8. Marsland BJ, Bättig P, Bauer M et al. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 2005 22 : 493 505.
9. Flanagan K, Moroziewicz D, Kwak H et al. The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells. Cell Immunol 2004 231 : 75 84.
10. Bonacchi A, Petrai I, Defranco RM et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003 125 : 1060 76.
11. Rangel-Moreno J, Moyron-Quiroz JE, Hartson L et al. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci USA 2007 104 : 10577 82.
12. Damås JK, Smith C, Øie E et al. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol 2007 27 : 614 20.
13. Saleh S, Solomon A, Wightman F et al. CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T-cells to HIV-1 infection: a novel model of HIV-1 latency. Blood 2007 110 : 4161 4.
14. Choi YK, Fallert BA, Murphey-Corb MA et al. Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo. Blood 2003 101 : 1684 91.
15. Damås JK, Landrø L, Fevang B et al. Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation to viral load, disease progression and response to HAART. AIDS 2009 23 : 135 8.
16. Hansen JB, Halvorsen DS, Haldorsen BC et al. Retention of phagocytic functions in cryopreserved human monocytes. J Leukoc Biol 1995 57 : 235 41.
17. Holm AM, Sivertsen EA, Tunheim SH et al. Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. Clin Exp Immunol 2004 138 : 278 89.
18. Byrnes HD, Kaminski H, Mirza A et al. Macrophage inflammatory protein-3 beta enhances IL-10 production by activated human peripheral blood monocytes and T cells. J Immunol 1999 163 : 4715 20.
19. Desai S, Chaparro A, Liu H et al. Impaired CCR7 expression on plasmacytoid dendritic cells of HIV-infected children and adolescents with immunologic and virologic failure. J Acquir Immune Defic Syndr 2007 45 : 501 7.
20. Aukrust P, Müller F, Lien E et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis 1999 179 : 74 82.
21. Nagira M, Sato A, Miki S et al. Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues. Virology 1999 264 : 422 6.
22. Kalantari P, Harandi OF, Hankey PA, Henderson AJ. HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation. J Immunol 2008 181 : 1548 55.
23. Norman JP, Perry SW, Reynolds HM et al. HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS ONE 2008 3 : e3731.
24. Xiao H, Neuveut C, Tiffany HL et al. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci USA 2000 97 : 11466 71.